Navigation Links
InVitria to Present at BIO 2009 International Convention in Atlanta
Date:5/19/2009

InVitria to profile "New Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone on May 20, 2009 in Atlanta, GA.

Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea of people, products and presentations at the BIO 2009 International Convention will be InVitria, a cell culture media supplement company that provides performance enhancing components for CHO and hybridoma cell culture media. InVitria's cell culture media supplement products will be part of the BIO Process Product Zone exhibition in Booth #5120 within the Georgia World Congress Center from May 18-21.

InVitria's products will also be showcased in the BioProcess Theater, a site located on the exhibition floor and sponsored by BioProcess International to facilitate the sharing of advances and discoveries in the biopharmaceutical sector. InVitria's Director of Cell Culture, Dr. Steve Pettit, will present the performance enhancing features of ZAP-CHO, a new media component for Chinese hamster ovary (CHO) cell culture. Dr. Pettit will present the advantages of this new cell culture supplement at 3:30 pm on Wednesday, May 20 inside the BioProcess Theater.

ZAP-CHO, a new product from InVitria, enhances performance of mammalian cell culture including improved cell growth and antibody production. It achieves these performance advantages in chemically defined media that are completely free of animal components. Previously, the performance seen with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum), BSA (bovine serum albumin) or plasma-derived HSA (human serum albumin) in cell culture media.

"Our team of scientists has developed supplements that not only meet the regulatory requirements of researchers using hybridoma and CHO cell culture, but it exceeds their performance expectations as well," said Dr. Pettit. "InVitria products have been utilized by customers to successfully achieve greater cell productivity and growth; faster cell doublings; and improved consistency."

About InVitria:
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's performance enhancing reagents, contact us at info @ InVitria.com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/BIO2009/ZAP-CHO/prweb2435574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Reveals Technology to Optimize Hybridoma Production Performance
2. InVitria Headlines Sponsorship of WilBio's Waterside Conference
3. InVitria Announces Launch of Recombinant Albumin for Diagnostics
4. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
5. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
6. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
7. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
8. InVitria to Present at WilBio's International Cell Engineering Meeting
9. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
10. Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
11. Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds ... the launch of a new DRTV campaign with Belly Bands. , Having a dog ... from sprays to puppy pads and find nothing works, get Belly Bands, the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 ... ... today announced the availability of the company's lighter, sleeker next generation LYNX VR ... assembly plant. , Improvements in design and manufacturing not only reduce the ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... 05, 2016 , ... After years as an active staff surgeon and having ... surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery at ... term as chief and began a second three-year term in January of 2016. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to ... may be safer than regular municipal or well water. The recent experience with lead ... Kleyne, could go a long way toward increasing public acceptance of recycled waste water ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016  Aethlon Medical, Inc. (Nasdaq: ... biofiltration devices to treat life-threatening diseases, today announced ... ended December 31, 2015. --> ... set forth in our last quarterly call, we ... our long-term objective to establish the Aethlon Hemopurifier® ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
Breaking Medicine Technology: